Muscle relaxants. Novelties and future development;Relajantes musculares. Novedades y líneas futuras

Actualizaciones en Anestesiologia y Reanimacion

Volumn 12, Issue 2, 2002, Pages 95-98

  Álvarez Gómez, José Antonio ^a  

^a Allergy Section   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

[N (3,4 DIACETOXYBENZYL)TROPINIUM 3ALPHA YL]GLUTARATE; CHLOROFURAMIC ACID; GAMMA CYCLODEXTRIN; GW 280430A; MUSCLE RELAXANT AGENT; RAPACURONIUM BROMIDE; SUGAMMADEX; TETRABUTYLAMMONIUM; TRIPEPTIDE; TROPINE; UNCLASSIFIED DRUG;

AMBULATORY SURGERY; HUMAN; INHALATION ANESTHESIA; INTUBATION; NEUROMUSCULAR BLOCKING; OPERATION DURATION; REVIEW;

EID: 0036317689     PISSN: 11320095     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Comparative neuromuscular blocking properties of GW 280430A and succinylcholine in humans
2. The effects of rapacuronium on histamine release and hemodynamics in adult patients undergoing general anesthesia
3. Hystory of development of neuromuscular blocking tropines
4. Alkoxy-acetoxy benzyl quaternary derivatives of tropinyl diesters ultrashort acting nondepolarizing muscle relaxant
5. Time course of the breakdown in blood of two new tropinyl diester type neuromuscular blocking agents
6. New, ultrashort acting muscle relaxants. Neuromuscular blocking profile on infusion administration in pigs
7. Effects on infusion administration of new ultrashort acting muscle relaxants in pigs
8. Non depolarizing neuromuscular blocking activity of bisquaternary amino di- and tripeptide derivatives
9. Studies in the search for new short-acting neuromuscular blocking agents
10. New fast neuromuscular blocking agent TAAC3 in the anesthetised monkey
11. New fast neuromuscular blocking agent TAAC3 in the anesthetised dog
12. Studies on a new rapid onset and short-acting neuromuscular blocking agent, TAAC3, in anaesthetised cats
13. Neuromuscular blocking effect of tetra-butyl ammonium compound and its interaction with vecuronium bromide in cats
14. Chemical chelation as a novel method of NMB reversal. Characterisation of the Org 25969 NMB Complex
15. Chemical chelation as a novel method of NMB reversal - Discovery of Org 25969
16. Neuromuscular blockade induced by steroidal NMBs can be rapidly reversed by Org 25969 in the anesthetised monkey
17. Org 25969 reverses rocuronium-induced neuromuscular blockade in the cat without important hemodynamic effects
18. Org 25969 causes selective reversal of neuromuscular block induced by steroidal NMB's in anesthetised guinea pigs
19. Adptative closed-loop feedback control of vecuronium-induced neuromuscular relaxation
20. Utilización de los bloqueantes neuromusculares en el futuro: Control automático en lazo cerrado de la relajación muscular
21. Quiantifying the interaction of vecuronium with enflurane using closed-loop feedback control of vecuronium infusión
22. Quantitation of the interaction between atracurium and succinylcholine using closed-loop feedback control of infusion of atracurium
23. Closed-loop infusion of atracurium with four different anesthetic techniques
24. Quantifying the interaction pf rocuronium (Org 9426) with etomidate, fentanyl, midazolam, propofol, thiopental and isoflurane using closed-loop feedback control of rocuronium infusion
25. Control automático de la infusión de bloqueantes neuromusculares. Perspectivas desde la lógica borrosa (Fuzzy Logic)
26. Desflurane reduces the effective therapeutic infusion rate (ETI) of cisatracurium more than isoflurane, sevoflurane or propofol
27. Fuzzy logic for model adaptation of a pharmacokinetic-based closed loop delivery system fro pancuronium